Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes

Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes

Background: Glucagon-like peptide-1 (GLP-1) agonists have emerged as a powerful diabetic treatment adjunct; however, its effects on outcomes following total knee arthroplasty (TKA) are not well known. The purpose of this study was to compare the risk of complications after TKA in patients with type-...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin Y. Heo, BS, Rahul K. Goel, MD, Andrew Fuqua, BS, Jeffrey S. Holmes, MD, Brian T. Muffly, MD, Greg A. Erens, MD, Jacob M. Wilson, MD, Ajay Premkumar, MD, MPH
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Arthroplasty Today
Subjects:
GLP-1 receptor agonist
Glucagon-like Peptide-1 receptor agonist
Complications
Total knee arthroplasty
Diabetes
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344124001912
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items